$4.09
2.15% yesterday
NYSE, Nov 15, 10:00 pm CET
ISIN
US2560861096
Symbol
DCGO

DocGo Stock price

$4.09
+0.89 27.81% 1M
+0.73 21.73% 6M
-1.50 26.83% YTD
-1.88 31.49% 1Y
-5.36 56.72% 3Y
-6.21 60.29% 5Y
-6.21 60.29% 10Y
NYSE, Closing price Fri, Nov 15 2024
-0.09 2.15%
ISIN
US2560861096
Symbol
DCGO
Sector

Key metrics

Market capitalization $426.57m
Enterprise Value $393.79m
P/E (TTM) P/E ratio 14.44
EV/FCF (TTM) EV/FCF 8.68
EV/Sales (TTM) EV/Sales 0.57
P/S ratio (TTM) P/S ratio 0.61
P/B ratio (TTM) P/B ratio 1.31
Revenue growth (TTM) Revenue growth 30.19%
Revenue (TTM) Revenue $694.97m
EBIT (operating result TTM) EBIT $47.84m
Free Cash Flow (TTM) Free Cash Flow $45.37m
Cash position $89.46m
EPS (TTM) EPS $0.29
P/E forward 16.50
P/S forward 0.68
EV/Sales forward 0.63
Short interest 7.08%
Show more

Is DocGo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

DocGo Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a DocGo forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a DocGo forecast:

Buy
100%

Financial data from DocGo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
695 695
30% 30%
100%
- Direct Costs 472 472
25% 25%
68%
223 223
43% 43%
32%
- Selling and Administrative Expenses 146 146
15% 15%
21%
- Research and Development Expense 11 11
18% 18%
2%
65 65
246% 246%
9%
- Depreciation and Amortization 17 17
14% 14%
2%
EBIT (Operating Income) EBIT 48 48
1,215% 1,215%
7%
Net Profit 31 31
319% 319%
4%

In millions USD.

Don't miss a Thing! We will send you all news about DocGo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DocGo Stock News

Neutral
Seeking Alpha
6 days ago
DocGo, Inc. (NASDAQ:DCGO ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Michael Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Pito Chickering - Deutsche Bank Ryan MacDonald - Needham Operator Welcome to DocGo, Inc. Third Quarter 2024 Earnings Call. [Operator Instructions].
Neutral
PRNewsWire
15 days ago
NEW YORK , Oct. 31, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives w...
Neutral
Business Wire
26 days ago
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the third quarter ended September 30, 2024 after the markets close on Thursday, November 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m....
More DocGo News

Company Profile

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Head office United States
CEO Bienstock Lee
Employees 4,100
Founded 2015
Website www.docgo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today